Overview

The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate

Status:
Completed
Trial end date:
2020-07-09
Target enrollment:
0
Participant gender:
Male
Summary
Perioperative bleeding is the most common complication related to transurethral resection of prostate, the aim of the study is to compare the effect of pre-operative use of finasteride versus Cyproterone acetate on blood loss with mono polar TURP
Phase:
Early Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Benha University
Treatments:
Cyproterone
Cyproterone Acetate
Finasteride
Criteria
Inclusion Criteria:

- Patients with benign prostatic hyperplasia with prostate size (60-100) grams

- Lower urinary tract symptoms (LUTS) not responding to medical treatment

- Recurrent prostatic bleeding

- Recurrent acute urinary retention

- Chronic urinary retention

Exclusion Criteria:

- Patients with coagulation disorders

- Previous prostatic surgery

- Previous finasteride administration

- Bladder pathology (urinary bladder stones - bladder mass)

- Suspected or proved cancer prostate

- Hepatic or renal impairment

- Patients unfit for operation eg. Decompensated heart failure, poor chest condition